HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
10 sources retrieved · Most recent: April 2026 · Index updated 14 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
STK24
serine/threonine kinase 24
Chromosome 13 · 13q32.2
NCBI Gene: 8428Ensembl: ENSG00000102572.15HGNC: HGNC:11403UniProt: B4DR80
104PubMed Papers
20Diseases
0Drugs
0Pathogenic Variants
FUNCTIONAL ROLE
Kinase
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
nucleusnucleoluscytosolFAR/SIN/STRIPAK complexmajor depressive disordertype 2 diabetes mellitusrisk-taking behaviourmathematical ability
✦AI Summary

STK24 is a serine/threonine kinase belonging to the MST (mammalian sterile twenty) family that regulates multiple cellular processes through phosphorylation of downstream targets. Primary functions include promotion of stress-induced apoptosis by modulating JNK and p38 MAPK phosphorylation during oxidative stress, and regulation of the STRIPAK complex involved in Hippo and MAPK signaling 1. STK24 also modulates excitatory synaptic transmission in hippocampal neurons, with reduced expression observed in epileptic tissue 2. In cancer biology, STK24 promotes lung adenocarcinoma (LUAD) progression through multiple mechanisms: it enhances cell proliferation and migration while suppressing apoptosis, acts downstream of the transcription factor KLF5, and activates the STAT3/VEGFA angiogenesis pathway 34. STK24 was identified as a LUAD risk locus through genome-wide association studies, with high expression correlating with poor patient prognosis 5. In hepatocellular carcinoma, STK24 activates the stress-responsive MASTL/YBX1/PAK4 axis driving lenvatinib resistance 6. Clinically, STK24 and its partner kinase STK25 inhibit cerebral cavernous malformation development, as their combined deficiency phenocopies CCM3 loss 7. The KLF5/STK24 and STK24/STAT3/VEGFA axes represent potential therapeutic targets for cancer treatment.

Sources cited
1
STK24 (MST3) is a member of the mammalian sterile twenty kinase family with roles in metabolic regulation and tissue homeostasis
PMID: 30882881
2
STK24 modulates excitatory synaptic transmission in epileptic neurons and is downregulated in epilepsy models
PMID: 32436359
3
STK24 is overexpressed in LUAD tissues, enhances proliferation and colony formation, and is activated by KLF5; high STK24 expression predicts poor survival
PMID: 37181807
4
STK24 promotes LUAD tumorigenesis and angiogenesis by positively regulating STAT3/VEGFA signaling through inhibition of STAT3 proteasomal degradation
PMID: 36720310
5
STK24 identified as LUAD risk locus through GWAS; STK24-positive epithelial cells promote progression via MIF and PDGF pathways; STK24 overexpression increases proliferation and colony formation while reducing apoptosis
PMID: 41168822
6
STK24 is a stress-activated kinase that phosphorylates and activates MASTL, which triggers the YBX1/PAK4 axis mediating lenvatinib resistance in HCC
PMID: 40456026
7
Combined STK24 and STK25 deficiency causes cavernous malformations in mice, indicating these kinases inhibit cavernoma development and require both kinases for this function
PMID: 35130716
8
STK24 is a GCKIII family kinase that partners with CCM3 protein in regulating vascular lesion development
PMID: 23744102
Disease Associationsⓘ20
major depressive disorderOpen Targets
0.46Moderate
type 2 diabetes mellitusOpen Targets
0.39Weak
risk-taking behaviourOpen Targets
0.39Weak
mathematical abilityOpen Targets
0.39Weak
Abnormal urine sodium concentrationOpen Targets
0.38Weak
anxiety disorderOpen Targets
0.34Weak
schizophreniaOpen Targets
0.32Weak
diabetes mellitusOpen Targets
0.31Weak
Tietze syndromeOpen Targets
0.31Weak
drug allergyOpen Targets
0.30Weak
ulcerative colitisOpen Targets
0.26Weak
corneal neovascularizationOpen Targets
0.25Weak
Alzheimer diseaseOpen Targets
0.23Weak
diabetic neuropathyOpen Targets
0.21Weak
obesityOpen Targets
0.20Weak
neurotic disorderOpen Targets
0.20Weak
gastroesophageal reflux diseaseOpen Targets
0.20Weak
intelligenceOpen Targets
0.19Weak
Abnormal blistering of the skinOpen Targets
0.12Weak
neoplasmOpen Targets
0.11Weak
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Related Genes
CCT4Protein interaction100%STRIP1Protein interaction100%STRN3Protein interaction100%STRIP2Protein interaction100%MOB4Protein interaction100%TRAF3IP3Protein interaction100%
Tissue Expression6 tissues
Brain
100%
Heart
57%
Lung
54%
Bone Marrow
51%
Ovary
36%
Liver
22%
Gene Interaction Network
Click a node to explore
STK24CCT4STRIP1STRN3STRIP2MOB4TRAF3IP3
PROTEIN STRUCTURE
Preparing viewer…
PDB3A7I · 1.45 Å · X-ray
View on RCSB ↗
Constraintⓘ
LOEUFⓘ
0.53Moderately Constrained
pLIⓘ
0.91Intolerant
Observed/Expected LoF0.35 [0.24–0.53]
RankingsWhere STK24 stands among ~20K protein-coding genes
  • #4,618of 20,598
    Most Researched104 · top quartile
  • #3,339of 17,882
    Most Constrained (LOEUF)0.53 · top quartile
Genes detectedSTK24
Sources retrieved10 papers
Response time—
📄 Sources
10▼
1
Genome-wide association, single-cell, and spatial transcriptomics analyses reveal the role of the STK24-expressing positive cells in LUAD progression and the tumor microenvironment, identifying STK24 as a potential therapeutic target.
PMID: 41168822
J Transl Med · 2025
1.00
2
MST Kinases and Metabolism.
PMID: 30882881
Endocrinology · 2019
0.90
3
GCKIII (Germinal Center Kinase III) Kinases STK24 and STK25 (Serine/Threonine Kinase 24 and 25) Inhibit Cavernoma Development.
PMID: 35130716
Stroke · 2022
0.80
4
STK24 Promotes Progression of LUAD and Modulates the Immune Microenvironment.
PMID: 37181807
Mediators Inflamm · 2023
0.70
5
The MASTL/YBX1/PAK4 axis regulated by stress-activated STK24 triggers lenvatinib resistance and tumor progression in HCC.
PMID: 40456026
Hepatology · 2026
0.60